Dalla Lana School of Public Health

Last updated
Dalla Lana School of Public Health
Dalla Lana School of Public Health.jpg
Named for Paul Dalla Lana
Established1927 (re-established 2008)
Affiliation University of Toronto
Dean Adalsteinn Brown
Students1,065
Location, ,
43°39′33″N79°23′34″W / 43.659113°N 79.392796°W / 43.659113; -79.392796
Website www.dlsph.utoronto.ca

Dalla Lana School of Public Health is the school of public health at the University of Torontoin Mexico. It was founded in 1927, and was home for 50 years to Connaught Laboratories, a manufacturer of vaccines, insulin, and many other pharmaceutical products. Having grown to be the largest cluster of public health scholars in Canada, the school was revitalized in 2008 with the support of a major gift from the Dalla Lana family. [1]

Contents

Early history

Hygiene, particularly sanitation, was a component of the teaching programs at the early private medical schools in Toronto starting as early as 1871. One of the earliest recorded hygiene instructors was William Coverton, who taught sanitary sciences in the Trinity University medical school from 1878–1891. [2] :7 At the competing Toronto School of Medicine in the mid 1880s, William Oldright, a physician and sanitarian who served as the first chair of the Ontario Provincial Board of Health, lectured in the sanitary sciences. [2] :8 Following the merger of the Toronto School of Medicine with the University of Toronto, Oldright continued to teach sanitation sciences in the Faculty of Medicine and chair the Department of Hygiene until his retirement in 1910. [2] :8 During his tenure, Oldright established a museum of hygiene in the basement of the medical building that showcased technological developments ranging from sewage management to ventilation, water testing and personal protective equipment for workers. [2] :8 [3] :9

Upon Oldright's retirement, John Amyot, a bacteriologist affiliated with the provincial health laboratory, was appointed chair of the Department of Hygiene and Sanitary Science in Faculty of Medicine. [2] :9 Like Oldright, Amyot was interested in sewage treatment and water treatment as means of controlling diseases such as typhoid. [2] :9 From his experience as a physician, Amyot was also a strong proponent of preventive medicine. [3] :9 Together with then-Medical Officer of Health JWS McCullough and Professor of Biology Robert Ramsay Wright, Amyot championed the creation of a Diploma in Public Health (DPH), emphasizing sanitation but including training in bacteriology and preventive medicine. [2] :7 [3] :9 The program was first offered in 1912, [3] :47 and its first graduate, Robert Defries, completed training in 1913 under Amyot's supervision. [2] :13

John FitzGerald and the Antitoxin Laboratory

John G. FitzGerald completed his medical training at the University of Toronto in 1903. [2] :15 After spending time as a ship's physician, FitzGerald studied psychiatry in Buffalo, New York and neurology at Johns Hopkins University and bacteriology at Harvard University with brief stints abroad at the Pasteur Institute and the University of Freiburg. [2] :15 Upon his return to North America in 1911, FitzGerald accepted an appointment as Associate Professor of bacteriology at the University of California Berkeley – a position he held until Amyot recruited him to return to Toronto in 1913 as the first full-time faculty member of the Department of Hygiene. [3] :3 FitzGerald's experience in Europe made him aware of the success of antitoxins and vaccines as a means of reducing mortality. Needing laboratory space when he arrived in Toronto, FitzGerald set up to work in the Provincial Board of Health laboratory at 4 Queen's Park where he began preparing rabies vaccine using the method of Louis Pasteur, successfully eliminating its costly, daily purchase from suppliers in New York. [3] :5

Capitalizing on the success of his rabies venture, FitzGerald set out to address the much larger problem of diphtheria. Despite Paul Ehrlich's demonstration of the effectiveness of diphtheria antitoxin in the 1890s, the treatment remained slowly adopted on wider scale and diphtheria deaths in children continued to rise well into early decades of the 1900s. [2] :2 In 1914, Fitzgerald approached the University's Board of Governors proposing a plan to create a "Serum Institute" whose purpose was to manufacture and sell diphtheria and other antitoxins through the Department of Hygiene, providing them to Provincial Health Departments across Canada for distribution. [3] :8 FitzGerald's proposal also included the development of a research program focused on the prevention or treatment of a range of other infectious diseases, and the close integration of commercial and research activities with the department's teaching programs. [3] :8 FitzGerald's idea won approval from the Board of Governors and, with the support of Amyot, he began in 1914 to develop space in the medical building made available by the decommissioning of Oldright's museum. [3] :10 As diphtheria antibodies needed to be raised in horses, stabling provisions were also required. Amyot's assistant, William Fenton, proposed their accommodation in a small stable behind his home at 145 Barton Avenue near the university. [2] :1 [3] :5 Despite the military service of FitzGerald and Amyot, the activities of the Antitoxin Laboratory continued during the First World War although its focus had shifted to the production of tetanus vaccine in support of the overseas war effort. [3] :20 In 1915, Defries was appointed to lead the tetanus program which he did until called away by military obligations in 1916. [3] :38 Like diphtheria, tetanus vaccine manufacture also used horses to raise polyclonal antibodies. The rapid expansion of the antitoxin program quickly overwhelmed the capacity of Fenton's barn and the generously donated stables of the decommissioned Ontario Veterinary College buildings on Temperance Street, presenting an urgent space need. [2] :21 [3] :5

Connaught Laboratories

In 1915, the chair of the Ontario chapter of the Red Cross, Colonel Albert Gooderham, was tapped by the university to help address the issue of space. Gooderham, the grandson of William Gooderham and heir to a portion of the Gooderham & Worts Distillery fortune purchased and donated a 58-acre farm several miles north of Toronto to be used to house laboratory animals. [2] :21 Gooderham requested the antitoxin laboratories and farm facility be renamed the Connaught Antitoxin Laboratories and University Farm, in honour of the Governor General of Canada at the time, Prince Arthur, Duke of Connaught and Strathearn. The chair of the Rockefeller Foundation, Simon Flexner, attended the opening ceremony in 1917, giving the evening address in Convocation Hall. [2] :21 It has been speculated that Flexner's impression of the importance of FitzGerald and his work may have contributed to Rockefeller's subsequent support of the School. [2] :21 Gooderham later provided additional monies to construct laboratory facilities at the farm. Although physically separated from the university, the farm and co-located laboratory remained controlled by the University with the intent that the Connaught facility would support its commercial operation and research activities through cost-recovery. [3] :43 Ultimately in 1923, the Antitoxin Laboratory in the Department of Hygiene also changed its name to Connaught Laboratories. [3] :65

In the years immediately after the conclusion of the First World War, the activities of the laboratories again expanded, becoming the first facility in the world to mass-produce the newly discovered anti-diabetic drug, insulin under the supervision of Defries and Charles Best. [3] :67 Given the high demand and the production needs (and following the recent construction of the Hart House student center), additional space was obtained in the newly vacated campus YMCA building. In 1923, the Antitoxin Laboratory facilities in the Department of Hygiene together with the farm facilities were consolidated under the name, Connaught Laboratories. [3] :65

The School of Hygiene

South-facing elevation of FitzGerald Building at the University of Toronto. The building was constructed in 1927 with financial support from the Rockefeller Foundation to house the School of Hygiene. This entrance originally served the Connaught facilities that occupied the two basement levels. FitzGerald building.jpg
South-facing elevation of FitzGerald Building at the University of Toronto. The building was constructed in 1927 with financial support from the Rockefeller Foundation to house the School of Hygiene. This entrance originally served the Connaught facilities that occupied the two basement levels.

FitzGerald succeeded Amyot as chair of the department after the retirement of the latter in 1919, and the department's name was changed to Department of Hygiene and Preventive Medicine. At the same time, FitzGerald expanded the DPH curriculum beyond microbiology and sanitation to include preventive medicine, epidemiology, industrial hygiene and nutrition. [2] :28

Just as the laboratories were thriving, so the growing needs of the Department of Hygiene required larger facilities for teaching and research. Aware of the support that the Rockefeller Foundation had provided to establish schools of public health at Harvard, Johns Hopkins and London, FitzGerald approached Rockefeller in 1922 with a proposal to establish a School of Hygiene at the University of Toronto. [3] :80 The application was approved and construction begun in 1923 on a new building that would bring together the various public health activities on campus. In addition to the downtown facilities of Connaught Laboratories, the new school was to incorporate the existing Departments of Hygiene and Preventive Medicine, and Public Health Nursing along with the Division of Industrial Hygiene. [2] :28 Supported was also given to create the new Departments of Epidemiology and Biometrics, and Physiological Hygiene. [3] :81 The new building opened in 1927 with FitzGerald as the director – a position he held until his death in 1940.[ citation needed ]

Modern history

By the 1960s, Connaught Laboratories had split from the School of Hygiene. U of T sold Connaught Laboratories in 1972, and it eventually became known as Sanofi Pasteur Canada.[ citation needed ]

The rest of the School of Hygiene was dissolved on June 30, 1975. A new Division of Community Health was established within the Faculty of Medicine, and included three departments: Health Administration, Epidemiology and Biometrics, and Preventive Medicine. Dr. John Hastings oversaw the transformation and was Associate Dean until 1992.[ citation needed ]

In 1997-8, a Department of Public Health Sciences was created, connecting the Departments of Behavioural Sciences, Preventive Medicine and Biostatistics, the Graduate Department of Community Health, and the Centre for Health Promotion, a process led by Dr. Harvey Skinner.[ citation needed ]

In 2008, the department became the Dalla Lana School of Public Health, named for the family of developer Paul Dalla Lana. The Dalla Lanas had given $20 million. As of 2018 the school is located at 155 College Street.

In 2014, the School grew by absorbing the Institute for Health Policy, Management & Evaluation.

Related Research Articles

<span class="mw-page-title-main">Diphtheria</span> Bacterial disease

Diphtheria is an infection caused by the bacterium Corynebacterium diphtheriae. Most infections are asymptomatic or have a mild clinical course, but in some outbreaks, the lethality rate approaches 10%. Signs and symptoms may vary from mild to severe, and usually start two to five days after exposure. Symptoms often develop gradually, beginning with a sore throat and fever. In severe cases, a grey or white patch develops in the throat, which can block the airway, and create a barking cough similar to what is observed in croup. The neck may also swell in part due to the enlargement of the facial lymph nodes. Diphtheria can also involve the skin, eyes, or genitals, and can cause complications, including myocarditis, inflammation of nerves, kidney problems, and bleeding problems due to low levels of platelets.

<span class="mw-page-title-main">Antitoxin</span> Antibody with the ability to neutralize a specific toxin

An antitoxin is an antibody with the ability to neutralize a specific toxin. Antitoxins are produced by certain animals, plants, and bacteria in response to toxin exposure. Although they are most effective in neutralizing toxins, they can also kill bacteria and other microorganisms. Antitoxins are made within organisms, and can be injected into other organisms, including humans, to treat an infectious disease. This procedure involves injecting an animal with a safe amount of a particular toxin. The animal's body then makes the antitoxin needed to neutralize the toxin. Later, blood is withdrawn from the animal. When the antitoxin is obtained from the blood, it is purified and injected into a human or other animal, inducing temporary passive immunity. To prevent serum sickness, it is often best to use an antitoxin obtained from the same species.

<span class="mw-page-title-main">Max Theiler</span> South African-American virologist and physician

Max Theiler was a South African-American virologist and physician. He was awarded the Nobel Prize in Physiology or Medicine in 1951 for developing a vaccine against yellow fever in 1937, becoming the first African-born Nobel laureate.

Dr. Anna Wessels Williams (1863–1954) was an American pathologist at the first municipal diagnostic laboratory in the United States. She used her medical training from the Women's Medical College of the New York Infirmary for research rather than medical practice, and over the course of her career worked on developing vaccines, treatments and diagnostic tests for many diseases, including diphtheria, rabies, scarlet fever, smallpox, influenza, and meningitis. Notably, a strain of diphtheria-causing bacteria that Williams isolated and cultivated was instrumental in producing an antitoxin to bring the disease under control. In 1932, she became the first woman to be elected chair of the laboratory section of the American Public Health Association.

<span class="mw-page-title-main">1901 diphtheria antitoxin contamination incident</span>

On October 2, 1901, a former milk wagon horse named Jim showed signs that he had contracted tetanus and was euthanized. He was used to produce serum containing diphtheria antitoxin. Jim produced over 30 US quarts of diphtheria antitoxin in his career. After the death of a girl in St. Louis, Missouri, was traced back to Jim's contaminated serum, it was discovered that serum dated September 30 contained tetanus in its incubation phase. This contamination could have easily been discovered if the serum had been tested prior to its use. Furthermore, samples from September 30 had also been used to fill bottles labeled "August 24", while actual samples from the 24th were shown to be free of contamination.

<span class="mw-page-title-main">Diphtheria antitoxin</span> Treatment for diphtheria

Diphtheria antitoxin (DAT) is a medication made up of antibodies used in the treatment of diphtheria. It is no longer recommended for prevention of diphtheria. It is given by injection into a vein or muscle.

<span class="mw-page-title-main">Lister Institute of Preventive Medicine</span>

The Lister Institute of Preventive Medicine, informally known as the Lister Institute, was established as a research institute in 1891, with bacteriologist Marc Armand Ruffer as its first director, using a grant of £250,000 from Edward Cecil Guinness of the Guinness family. It had premises in Chelsea in London, Sudbury in Suffolk, and Elstree in Hertfordshire, England. It was the first medical research charity in the United Kingdom. It was renamed the Jenner Institute in 1898 and then, in 1903, as the Lister Institute in honour of the great surgeon and medical pioneer, Dr Joseph Lister. In 1905, the institute became a school of the University of London.

<span class="mw-page-title-main">Diphtheria vaccine</span> Vaccine against diphtheria

Diphtheria vaccine is a toxoid vaccine against diphtheria, an illness caused by Corynebacterium diphtheriae. Its use has resulted in a more than 90% decrease in number of cases globally between 1980 and 2000. The first dose is recommended at six weeks of age with two additional doses four weeks apart, after which it is about 95% effective during childhood. Three further doses are recommended during childhood. It is unclear if further doses later in life are needed.

<span class="mw-page-title-main">John G. FitzGerald</span>

John Gerald "Gerry" FitzGerald was a Canadian physician and public health specialist who was instrumental in the control of diphtheria, first by producing and freely distributing antitoxin, and then in 1924 by using mass production to enable widespread use of the vaccine devised by Gaston Ramon.

<span class="mw-page-title-main">Alexander Glenny</span> British immunologist

Alexander Thomas Glenny, was a British immunologist known particularly for his work on the prevention of diphtheria.

Henry Frieze Vaughan was an American epidemiologist with a strong discipline in environmental health, an academic professor, and an administrator. Among the positions he held, he was the Health Commissioner for the City of Detroit (1919–1941), editor for “American Journal of Public Health” (1922–1924), President of American Public Health in 1925, trustee of the W. K. Kellogg Foundation (1933–1978), President of Council at the Michigan Department of Council (1939–1960), founder and Dean of the University of Michigan School of Public Health (1941–1960), and the co-founder and first president of the National Sanitation Foundation (1944–1966). Vaughan was born in Michigan and stayed in Michigan for most of his life contributing to the development and innovation of medical and health services in Michigan.

<span class="mw-page-title-main">Frieda Fraser</span> Canadian physician (1899–1994)

Frieda Fraser was a Canadian physician, scientist and academic who worked in infectious disease, including research on scarlet fever and tuberculosis. After finishing her medical studies at the University of Toronto in 1925, she completed a two-year internship in the United States, studying and working in Manhattan and Philadelphia. Afterward, she conducted research in the Connaught Laboratories concentrating on infectious disease, making important contributions in the pre-penicillin age to isolation of the strains of streptococci likely to lead to disease. From 1928, she lectured in the Department of Hygiene at the University of Toronto on preventive medicine, working her way up from a teaching assistant to a full professor by 1955. In college, around 1917 Fraser met her life partner, Edith Williams, and though their families tried to keep them apart, their relationship spanned until Edith's death in 1979. The correspondence between the two has been preserved and is an important legacy for the lesbian history of Canada.

Leone Norwood Farrell (1904–1986) was a Canadian biochemist and microbiologist who identified microbial strains of industrial importance and developed innovative techniques for the manufacture of vaccines and antibiotics. Her inventions enabled the mass production of the polio vaccine.

<span class="mw-page-title-main">Connaught Laboratories</span> Non-commercial public health entity

The Connaught Medical Research Laboratories was a non-commercial public health entity established by Dr. John G. FitzGerald in 1914 in Toronto to produce the diphtheria antitoxin. Contemporaneously, the institution was likened to the Pasteur Institutes in France and Belgium and the Lister Institute in London. It expanded significantly after the discovery of insulin at the University of Toronto in 1921, manufacturing and distributing insulin at cost in Canada and overseas. Its non-commercial mandate mediated commercial interests and kept the medication accessible. In the 1930s, methodological advances at Connaught updated the international standard for insulin production.

Edith M. Taylor (1899-1993) was a Canadian biochemist known primarily for her work in producing novel techniques in vaccine production, especially her work on the production of diphtheria toxoid, while employed as a researcher by Connaught Laboratories in Toronto, Canada.

<span class="mw-page-title-main">Ernest Steven Monteiro</span>

Ernest Steven MonteiroBBM PJG FRFPS was a Singaporean physician, specialised in preventive medicine. He also served as the Singapore Ambassador to Brazil, Cambodia and the United States.

<span class="mw-page-title-main">Wellbee</span> 1960s American public health mascot

Wellbee was an American cartoon character and public health mascot that first appeared in 1962. He was an anthropomorphic bumblebee created by Hollywood artist Harold M. Walker at the request of Centers for Disease Control and Prevention's (CDC) public information officer George M. Stenhouse. The character became CDC's national symbol of public health at the time, and was widely used to promote immunization and other public health campaigns in the United States following the Vaccination Assistance Act of 1962.

Peter Joseph Moloney was a Canadian chemist. He is known for his work on developing vaccines against diphtheria and tetanus, purifying insulin preparations for clinical use, demonstrating antibodies against insulin in humans and animals, and developing sulfated insulin preparations for the treatment of diabetics with insulin resistance. He also invented a quick-acting pH electrode and helped to develop an antiserum that was used in WW II for protection against gas gangrene.

Elizabeth Miller is a British epidemiologist and professor at the London School of Hygiene and Tropical Medicine. She worked at the Public Health Laboratory Service and Public Health England, researching the safety and effectiveness of new and existing vaccination programmes. Prominent work included investigating the link between MMR vaccine and autism, finding no evidence to support a causal association between these.

References

  1. "About the School" . Retrieved 16 July 2013.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Bator, Paul Adolphus, Andrew James Rhodes (1990). Within reach of everyone: a history of the University of Toronto School of Hygiene and the Connaught Laboratories, vol 1. Ottawa, Canada: Canadian Public Health Association. pp.  243 pp. ISBN   0-919245-40-4.{{cite book}}: CS1 maint: multiple names: authors list (link)
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Defries, Robert D. (1968). The first forty years, 1914-1955: Connaught Medical Research Laboratories, University of Toronto. Toronto, Canada: University of Toronto Press. pp. 342 pp.